AGP Executive Report
Last update: 3 hours agoBiotech Breakthrough: Researchers across Europe are pushing toward a “functional cure” for chronic hepatitis B, with a new vaccine effort aimed at people already living with the virus; in the EU, Iceland, Liechtenstein and Norway, about 3.6 million people are chronically infected. AI Infrastructure & Energy: Scotland’s rush to approve large “hyperscale” AI data centres is drawing backlash over transparency, environmental impact, and heavy energy and water use. Cancer Drug Deal (EU/UK/LI): IMPACT Therapeutics and Pharmanovia signed an exclusive licensing partnership for senaparib, covering Europe (including Liechtenstein), with total potential value up to €423.5M and an EMA review expected to land in 2H 2026. Health Tech (EU/LI): The European Commission authorized Pfizer-BioNTech’s XFG-adapted COVID-19 vaccine for ages 6+ across the EU plus Iceland, Liechtenstein and Norway. Crypto Regulation: ESMA added 15 crypto-asset service providers to its MiCA register, bringing the total to 309, including BNY’s Belgian unit for custody and transfer services. Climate & Industry: Europe’s heatwaves are also hitting shipping as the Rhine and Danube drop to record-low levels, threatening full-load cargo and disrupting major industries. Local Tech Industry (Liechtenstein): Neutrik, the Liechtenstein pro-audio connector maker, highlights its 50-year growth and global push via Neutrik Americas.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.